These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 27866766)

  • 1. Age-specific effectiveness following each dose of acellular pertussis vaccine among infants and children in New Zealand.
    Radke S; Petousis-Harris H; Watson D; Gentles D; Turner N
    Vaccine; 2017 Jan; 35(1):177-183. PubMed ID: 27866766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pertussis vaccine effectiveness in a frequency matched population-based case-control Canadian Immunization Research Network study in Ontario, Canada 2009-2015.
    Crowcroft NS; Schwartz KL; Chen C; Johnson C; Li Y; Marchand-Austin A; Bolotin S; Jamieson FB; Drews SJ; Russell ML; Svenson LW; Simmonds K; Mahmud SM; Kwong JC
    Vaccine; 2019 May; 37(19):2617-2623. PubMed ID: 30967309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001.
    Bisgard KM; Rhodes P; Connelly BL; Bi D; Hahn C; Patrick S; Glodé MP; Ehresmann KR;
    Pediatrics; 2005 Aug; 116(2):e285-94. PubMed ID: 16061582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acellular pertussis vaccine effectiveness for children during the 2009-2010 pertussis epidemic in Queensland.
    Sheridan SL; McCall BJ; Davis CA; Robson JM; Hull BP; Selvey CE; Ware RS; Grimwood K; Lambert SB
    Med J Aust; 2014 Apr; 200(6):334-8. PubMed ID: 24702091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of routine and booster pertussis vaccination in children and adolescents, federal state of Brandenburg, Germany, 2002-2012.
    Haller S; Dehnert M; Karagiannis I; Rieck T; Siffczyk C; Wichmann O; Poethko-Mueller C; Hellenbrand W
    Pediatr Infect Dis J; 2015 May; 34(5):513-9. PubMed ID: 25621762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Duration of protection after first dose of acellular pertussis vaccine in infants.
    Quinn HE; Snelling TL; Macartney KK; McIntyre PB
    Pediatrics; 2014 Mar; 133(3):e513-9. PubMed ID: 24515514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced risk of pertussis in whole-cell compared to acellular vaccine recipients is not confounded by age or receipt of booster-doses.
    Sheridan SL; Ware RS; Grimwood K; Lambert SB
    Vaccine; 2015 Sep; 33(39):5027-30. PubMed ID: 26297874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unexpectedly limited durability of immunity following acellular pertussis vaccination in preadolescents in a North American outbreak.
    Witt MA; Katz PH; Witt DJ
    Clin Infect Dis; 2012 Jun; 54(12):1730-5. PubMed ID: 22423127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A cross-sectional study of Bordetella pertussis seroprevalence and estimated duration of vaccine protection against pertussis in St. Petersburg, Russia.
    Kurova N; Timofeeva EV; Guiso N; Macina D
    Vaccine; 2018 Dec; 36(52):7936-7942. PubMed ID: 30448334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of childhood pertussis with receipt of 5 doses of pertussis vaccine by time since last vaccine dose, California, 2010.
    Misegades LK; Winter K; Harriman K; Talarico J; Messonnier NE; Clark TA; Martin SW
    JAMA; 2012 Nov; 308(20):2126-32. PubMed ID: 23188029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-lived immunity against pertussis, age-specific routes of transmission, and the utility of a teenage booster vaccine.
    Lavine JS; Bjørnstad ON; de Blasio BF; Storsaeter J
    Vaccine; 2012 Jan; 30(3):544-51. PubMed ID: 22119924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A nested case-control study measuring pertussis vaccine effectiveness and duration of protection in Manitoba, Canada, 1992-2015: A Canadian Immunization Research Network Study.
    Wilkinson K; Righolt CH; Kwong JC; Schwartz KL; Russell ML; Crowcroft NS; Mahmud SM
    Vaccine; 2019 Nov; 37(48):7132-7137. PubMed ID: 31564453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term follow-up of Swedish children vaccinated with acellular pertussis vaccines at 3, 5, and 12 months of age indicates the need for a booster dose at 5 to 7 years of age.
    Gustafsson L; Hessel L; Storsaeter J; Olin P
    Pediatrics; 2006 Sep; 118(3):978-84. PubMed ID: 16950988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experience with monocomponent acellular pertussis combination vaccines for infants, children, adolescents and adults--a review of safety, immunogenicity, efficacy and effectiveness studies and 15 years of field experience.
    Thierry-Carstensen B; Dalby T; Stevner MA; Robbins JB; Schneerson R; Trollfors B
    Vaccine; 2013 Oct; 31(45):5178-91. PubMed ID: 23994021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of acellular pertussis preschool booster vaccination on disease burden of pertussis in The Netherlands.
    de Greeff SC; Mooi FR; Schellekens JF; de Melker HE
    Pediatr Infect Dis J; 2008 Mar; 27(3):218-23. PubMed ID: 18277916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of immunisation strategies for pertussis vaccines in Jinan, China - an interrupted time-series study.
    Liu TC; Zhang J; Liu SQ; Yin AT; Ruan SM
    Epidemiol Infect; 2020 Feb; 148():e26. PubMed ID: 32046804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Waning vaccine immunity in teenagers primed with whole cell and acellular pertussis vaccine: recent epidemiology.
    Sheridan SL; Frith K; Snelling TL; Grimwood K; McIntyre PB; Lambert SB
    Expert Rev Vaccines; 2014 Sep; 13(9):1081-106. PubMed ID: 25093268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose-dependent effectiveness of acellular pertussis vaccine in infants: A population-based case-control study.
    Mack I; Erlanger TE; Lang P; Sinniger P; Perisa D; Heininger U
    Vaccine; 2020 Feb; 38(6):1444-1449. PubMed ID: 31813648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pertussis vaccination in infancy lowers the incidence of pertussis disease and the rate of hospitalisation after one and two doses: analyses of 10 years of pertussis surveillance.
    Nilsson L; Lepp T; von Segebaden K; Hallander H; Gustafsson L
    Vaccine; 2012 May; 30(21):3239-47. PubMed ID: 22094282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Whooping cough—where are we now? A review.
    Kiedrzynski T; Bissielo A; Suryaprakash M; Bandaranayake D
    N Z Med J; 2015 Jun; 128(1416):21-7. PubMed ID: 26117672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.